Central Nervous System Tumor Clinical Trial
Official title:
Somatic Mosaicism in Twins Discordant for Childhood Cancer: a Pilot Study
Somatic mosaicism in cancer associated genes is one potential explanation for discordance in childhood cancer that has not been fully explored to date. This pilot study will focus on twins with central nervous system (CNS) tumors who are identified through the Children's Oncology Group's Project: EveryChild (PEC) registry or volunteer.
PRIMARY OBJECTIVES: I. To conduct a descriptive study of same sex twins (MZ and DZ) discordant for childhood CNS tumors identified through the Children's Oncology Group Project:EveryChild registry. II. To compare the prevalence of somatic mosaicism in classic cancer-associated genes in monozygotic (MZ) twins discordant for childhood brain tumors. In our pilot study, we will sequence blood and saliva DNA samples from 25 MZ twin pairs using a panel of 94 known cancer associated genes. SECONDARY OBJECTIVES: I. To compare the profile of mutations detected in DNA extracted from pre- and post-treatment blood samples from a subset of CNS tumor patients. The purpose of this aim is to ensure that differences in somatic mosaicism detected in twin pairs are not caused by cancer therapy. Outline: Twins with CNS tumors will undergo blood and saliva DNA samples with the goal is to learn more about genetic differences that may lead to CNS tumor development. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04743310 -
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
|
Phase 2 | |
Completed |
NCT02496520 -
Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults
|
Phase 1/Phase 2 | |
Completed |
NCT00002594 -
Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors
|
Phase 2 | |
Active, not recruiting |
NCT02932280 -
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
|
Phase 1/Phase 2 | |
Completed |
NCT00078988 -
High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas
|
Phase 3 | |
Recruiting |
NCT06104488 -
A Study of Avutometinib for People With Solid Tumor Cancers
|
Phase 1 | |
Completed |
NCT00238264 -
Radiation Therapy in Treating Young Patients With Gliomas
|
Phase 2 | |
Completed |
NCT00006024 -
Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
|
Phase 1 | |
Recruiting |
NCT02012699 -
Integrated Cancer Repository for Cancer Research
|
||
Completed |
NCT03981016 -
Medical and Surgical Management of Patients With Brain Metastases
|
N/A | |
Completed |
NCT00716976 -
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
|
Phase 3 | |
Recruiting |
NCT05978557 -
Brain Slice Explants to Predict Drug Response in Brain Tumors
|
||
Recruiting |
NCT04852354 -
Tissue Collection for Drug Screening and Bioanalysis
|
||
Completed |
NCT00077207 -
Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
|
N/A | |
Completed |
NCT00085098 -
Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor
|
Phase 3 | |
Active, not recruiting |
NCT03052738 -
Medical Marijuana in the Pediatric Central Nervous System Tumor Population
|
||
Recruiting |
NCT03452774 -
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
|
||
Terminated |
NCT04096716 -
Mapping Draining Lymph Nodes in CNS Malignancies
|
Phase 1 | |
Recruiting |
NCT01595126 -
Longitudinal Study of Biomarkers
|
N/A | |
Recruiting |
NCT04185038 -
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
|
Phase 1 |